121 related articles for article (PubMed ID: 12231563)
1. Contribution of double-stranded RNA-activated protein kinase toward antiproliferative actions of heparin on vascular smooth muscle cells.
Patel RC; Handy I; Patel CV
Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1439-44. PubMed ID: 12231563
[TBL] [Abstract][Full Text] [Related]
2. STAT1 requirement for PKR-induced cell cycle arrest in vascular smooth muscle cells in response to heparin.
Handy I; Patel RC
Gene; 2013 Jul; 524(1):15-21. PubMed ID: 23597922
[TBL] [Abstract][Full Text] [Related]
3. Isolation of heparin-insensitive aortic smooth muscle cells. Growth and differentiation.
San Antonio JD; Karnovsky MJ; Ottlinger ME; Schillig R; Pukac LA
Arterioscler Thromb; 1993 May; 13(5):748-57. PubMed ID: 8485126
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
Kim TJ; Yun YP
Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
[TBL] [Abstract][Full Text] [Related]
5. Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells.
Castellot JJ; Pukac LA; Caleb BL; Wright TC; Karnovsky MJ
J Cell Biol; 1989 Dec; 109(6 Pt 1):3147-55. PubMed ID: 2592420
[TBL] [Abstract][Full Text] [Related]
6. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization.
Logeart D; Prigent-Richard S; Jozefonvicz J; Letourneur D
Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134
[TBL] [Abstract][Full Text] [Related]
7. Heparin inhibits phosphorylation and autonomous activity of Ca(2+)/calmodulin-dependent protein kinase II in vascular smooth muscle cells.
Mishra-Gorur K; Singer HA; Castellot JJ
Am J Pathol; 2002 Nov; 161(5):1893-901. PubMed ID: 12414535
[TBL] [Abstract][Full Text] [Related]
8. COP-1, a member of the CCN family, is a heparin-induced growth arrest specific gene in vascular smooth muscle cells.
Delmolino LM; Stearns NA; Castellot JJ
J Cell Physiol; 2001 Jul; 188(1):45-55. PubMed ID: 11382921
[TBL] [Abstract][Full Text] [Related]
9. Regulation of vascular smooth muscle proliferation by heparin: inhibition of cyclin-dependent kinase 2 activity by p27(kip1).
Fasciano S; Patel RC; Handy I; Patel CV
J Biol Chem; 2005 Apr; 280(16):15682-9. PubMed ID: 15731113
[TBL] [Abstract][Full Text] [Related]
10. Heparin sensitive and resistant vascular smooth muscle cells: biology and role in restenosis.
San Antonio JD; Verrecchio A; Pukac LA
Connect Tissue Res; 1998; 37(1-2):87-103. PubMed ID: 9643650
[TBL] [Abstract][Full Text] [Related]
11. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serum.
Grainger DJ; Witchell CM; Watson JV; Metcalfe JC; Weissberg PL
Cardiovasc Res; 1993 Dec; 27(12):2238-47. PubMed ID: 8313434
[TBL] [Abstract][Full Text] [Related]
12. Derivatized dextran inhibition of smooth muscle cell proliferation.
Avramoglou T; Jozefonvicz J
J Biomater Sci Polym Ed; 1991; 3(2):149-54. PubMed ID: 1722699
[TBL] [Abstract][Full Text] [Related]
13. Heparin suppresses sgk, an early response gene in proliferating vascular smooth muscle cells.
Delmolino LM; Castellot JJ
J Cell Physiol; 1997 Dec; 173(3):371-9. PubMed ID: 9369950
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of PKR improves vascular inflammation and remodelling in high fructose treated primary vascular smooth muscle cells.
Kalra J; Mangali S; Bhat A; Jadhav K; Dhar A
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165606. PubMed ID: 31740405
[TBL] [Abstract][Full Text] [Related]
15. The antimitogenic action of the sulphated polysaccharide fucoidan differs from heparin in human vascular smooth muscle cells.
Patel MK; Mulloy B; Gallagher KL; O'Brien L; Hughes AD
Thromb Haemost; 2002 Jan; 87(1):149-54. PubMed ID: 11848445
[TBL] [Abstract][Full Text] [Related]
16. Effect of heparin-derived oligosaccharide on bFGFR1 and bFGFR2 in vascular smooth muscle cells.
Yu D; Rui X; He S
Vasc Endovascular Surg; 2014 May; 48(4):289-96. PubMed ID: 24472831
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative effects of A02011-1, an adenylyl cyclase activator, in cultured vascular smooth muscle cells of rat.
Yu SM; Cheng ZJ; Kuo SC
Br J Pharmacol; 1995 Mar; 114(6):1227-35. PubMed ID: 7620713
[TBL] [Abstract][Full Text] [Related]
18. Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells.
Ottlinger ME; Pukac LA; Karnovsky MJ
J Biol Chem; 1993 Sep; 268(26):19173-6. PubMed ID: 7690027
[TBL] [Abstract][Full Text] [Related]
19. Clitocybin B inhibits rat aortic smooth muscle cell proliferation through suppressing PDGF-Rβ phosphorylation.
Yoo KD; Park ES; Lim Y; Kang SI; Yoo SH; Won HH; Lee HP; Kim YH; Yoo ID; Yoo HS; Hong JT; Yun YP
Vascul Pharmacol; 2012; 56(1-2):91-7. PubMed ID: 22166585
[TBL] [Abstract][Full Text] [Related]
20. Role of p44/p42 MAP kinase in the age-dependent increase in vascular smooth muscle cell proliferation and neointimal formation.
Gennaro G; Ménard C; Giasson E; Michaud SE; Palasis M; Meloche S; Rivard A
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):204-10. PubMed ID: 12588760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
